Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Genzyme COO: David Meeker will fill the newly created role of chief operating officer, the diversified biotechnology firm said March 30. The new position integrates all aspects of Genzyme's commercial organization. With Genzyme since 1994, Meeker has headed the Genetic Diseases, Biosurgery and Transplant businesses, and in 2009 initiated the transformation of the company's global manufacturing and quality operations. He will now oversee the firm's business units, country management organization and global market access functions

You may also be interested in...



People In Brief

Biotronik CRM: Veteran Medtronic cardiac rhythm management unit executive Patrick L. Horan joins Biotronik May 14 as VP of corporate sales for U.S. operations, where he will help drive sales for implantable cardioverter defibrillators and pacemakers. The Berlin-based cardiovascular device company has increased efforts in the past several years to push into the U.S. CRM market, still dominated by Medtronic, Boston Scientific and St. Jude Medical. Horan left Medtronic last year and briefly went to surgical device firm Synovis Life Technologies before joining Biotronik. Horan has also been active in the group purchasing organization community as a board member of the Health Industry Group Purchasing Association (1"The Gray Sheet" Dec. 14, 2009)

People In Brief

Biotronik CRM: Veteran Medtronic cardiac rhythm management unit executive Patrick L. Horan joins Biotronik May 14 as VP of corporate sales for U.S. operations, where he will help drive sales for implantable cardioverter defibrillators and pacemakers. The Berlin-based cardiovascular device company has increased efforts in the past several years to push into the U.S. CRM market, still dominated by Medtronic, Boston Scientific and St. Jude Medical. Horan left Medtronic last year and briefly went to surgical device firm Synovis Life Technologies before joining Biotronik. Horan has also been active in the group purchasing organization community as a board member of the Health Industry Group Purchasing Association (1"The Gray Sheet" Dec. 14, 2009)

People In Brief

David Jenkins returns as EP MedSystems CEO: EP MedSystems Chairman and Founder David Jenkins is named president, CEO and COO after the board of directors fires Reinhard Schmidt for "cause." An internal audit found that Schmidt made inaccurate statements to the Department of Commerce and the U.S. Attorney's Office for the District of New Jersey during an investigation into the firm's product sales to Iran, which are forbidden by U.S. law. The government is also investigating the accuracy of statements certified and authorized by Schmidt. No financial irregularities have been discovered. Jenkins, who served as EP MedSystems' CEO from 1993-2002, headed up gastric electrical stimulation device developer Transneuronix before Medtronic acquired it for $260 mil. in July (1"The Gray Sheet" July 4, 2005, p. 10)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028706

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel